Safety and Efficacy of GLP‐1 Receptor Agonists in Adults With Epilepsy, Obesity, and Type 2 Diabetes
ABSTRACT Objective Managing obesity in patients with epilepsy is complicated by the weight‐gaining properties of essential antiseizure medications (ASMs) such as valproate and pregabalin. We evaluated the safety and efficacy of initiating glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) in this population.
Hyoshin Son +3 more
wiley +1 more source
Graph convolution network based on meta-paths and mutual information for drug-target interaction prediction. [PDF]
Cao S +5 more
europepmc +1 more source
ABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a devastating neurological disease that lacks serological biomarkers that can accurately reflect disease activity. We established a live cell‐based assay (LCBA) using serum with endogenous complement to quantify the overall cytotoxicity, offering a novel functional tool for monitoring
Xiaona Xu +10 more
wiley +1 more source
Enhancing drug repositioning: A multi-class ensemble model for drug-target interaction prediction with action type categorization. [PDF]
Jafari Khouzani L +4 more
europepmc +1 more source
ABSTRACT Background The clinical relevance of MGMT promoter methylation in IDH‐mutant gliomas remains controversial in the era of molecular classification. We aimed to systematically evaluate its clinical relevance by integrating quantitative assessment, cutoff exploration, and adjustment for clinical confounding.
Haihui Jiang +7 more
wiley +1 more source
AI-powered IC50 prediction for p53 inhibitors drug-target interaction via hybrid graph neural networks. [PDF]
El-Masry WH +3 more
europepmc +1 more source
BiMA-DTI: a bidirectional Mamba-Attention hybrid framework for enhanced drug-target interaction prediction. [PDF]
Shui Y +5 more
europepmc +1 more source
SaeGraphDTI: drug-target interaction prediction based on sequence attribute extraction and graph neural network. [PDF]
Zhang Q +5 more
europepmc +1 more source
SP-DTI: subpocket-informed transformer for drug-target interaction prediction. [PDF]
Liu S, Liu Y, Xu H, Xia J, Li SZ.
europepmc +1 more source
Accurate and transferable drug-target interaction prediction with DrugLAMP. [PDF]
Luo Z, Wu W, Sun Q, Wang J.
europepmc +1 more source

